Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03834961
Title Larotrectinib in Treating Patients With Previously Untreated TRK Fusion Solid Tumors and TRK Fusion Relapsed Acute Leukemia
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Children's Oncology Group
Indications

Advanced Solid Tumor

acute leukemia

childhood fibrosarcoma

Therapies

Larotrectinib

Age Groups: child | adult
Covered Countries USA | CAN


No variant requirements are available.